Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.229NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.415NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.370NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.421NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.428.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.612NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.305NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JA.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.1.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.2.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.9.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.3.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JV.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.4.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.35NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LF.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.3.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LQ.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LY.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MD.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MK.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LZ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MB.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.3.2.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.50NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
unclassifiableNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KS.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HH.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XCENChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HN.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GU.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.6.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.18NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used